# A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease

> **NCT02265276** · PHASE3 · UNKNOWN · sponsor: **Command Hospital, India** · enrollment: 100 (estimated)

## Conditions studied

- Fatty Liver

## Interventions

- **DRUG:** Saroglitazar
- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT02265276
- **Lead sponsor:** Command Hospital, India
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02265276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02265276, "A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02265276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*